Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection
Kai-Ming Leng,1,* Yue-Ping Liu,1,* Zhi-Dong Wang,1 Xiang-Yu Zhong,1 Guan-Qun Liao,2 Peng-Cheng Kang,1 Yun-Fu Cui,1 Xing-Ming Jiang1 1Department of Hepatopan­creatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, 2Department of General Surgery, Foshan Hospita...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/results-of-adjuvant-radiation-therapy-for-locoregional-perihilar-chola-peer-reviewed-article-OTT |
id |
doaj-4827fabc106048b88fc506498509381f |
---|---|
record_format |
Article |
spelling |
doaj-4827fabc106048b88fc506498509381f2020-11-24T23:10:18ZengDove Medical PressOncoTargets and Therapy1178-69302017-04-01Volume 102257226632515Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resectionLeng KMLiu YPWang ZDZhong XYLiao GQKang PCCui YFJiang XMKai-Ming Leng,1,* Yue-Ping Liu,1,* Zhi-Dong Wang,1 Xiang-Yu Zhong,1 Guan-Qun Liao,2 Peng-Cheng Kang,1 Yun-Fu Cui,1 Xing-Ming Jiang1 1Department of Hepatopan­creatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, 2Department of General Surgery, Foshan Hospital Affiliated to Southern Medical University, Foshan, People’s Republic of China *These authors contributed equally to this work Purpose: This study sought to define the role of adjuvant radiation therapy (RT) for patients with curative intent resection of perihilar cholangiocarcinoma (pCCA).Patients and methods: By using the Surveillance, Epidemiology and End Results (SEER) registry, 1,917 patients with non-metastatic pCCA who underwent surgical resection from 1988 to 2009 were included in this study. Propensity score methods were used to compare the survival outcomes of patients treated with and without adjuvant RT after controlling for selection bias.Results: Of the 1,917 patients, 762 (39.7%) received adjuvant RT. In the unmatched population, median overall survival (OS) for patients receiving adjuvant RT compared with those undergoing surgery alone was 23 versus 22 months (P=0.651). Patients who received adjuvant RT were younger (65 vs 68 years, P<0.001), had more regional diseases (86.0% vs 76.7%, P<0.001), and had more positive lymph nodes (43.8% vs 32.2%, P<0.001). In the matched population, adjuvant RT did not show better OS (22 vs 23 months, P=0.978) or cancer-specific survival (CSS) (17 vs 18 months, P=0.554).Conclusion: Adjuvant RT is not associated with improved survival of patients with resected pCCA. These data suggest that adjuvant RT should not be routinely used to treat patients with pCCA outside research trials. Ideally, prospective randomized trials should be performed to verify the conclusion of this study. Keywords: perihilar cholangiocarcinoma, radiation therapy, SEER, propensity score, survival, surgeryhttps://www.dovepress.com/results-of-adjuvant-radiation-therapy-for-locoregional-perihilar-chola-peer-reviewed-article-OTTHilar cholangiocarcinomaRadiation therapySEERSurvivalSurgery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Leng KM Liu YP Wang ZD Zhong XY Liao GQ Kang PC Cui YF Jiang XM |
spellingShingle |
Leng KM Liu YP Wang ZD Zhong XY Liao GQ Kang PC Cui YF Jiang XM Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection OncoTargets and Therapy Hilar cholangiocarcinoma Radiation therapy SEER Survival Surgery |
author_facet |
Leng KM Liu YP Wang ZD Zhong XY Liao GQ Kang PC Cui YF Jiang XM |
author_sort |
Leng KM |
title |
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection |
title_short |
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection |
title_full |
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection |
title_fullStr |
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection |
title_full_unstemmed |
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection |
title_sort |
results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection |
publisher |
Dove Medical Press |
series |
OncoTargets and Therapy |
issn |
1178-6930 |
publishDate |
2017-04-01 |
description |
Kai-Ming Leng,1,* Yue-Ping Liu,1,* Zhi-Dong Wang,1 Xiang-Yu Zhong,1 Guan-Qun Liao,2 Peng-Cheng Kang,1 Yun-Fu Cui,1 Xing-Ming Jiang1 1Department of Hepatopan­creatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, 2Department of General Surgery, Foshan Hospital Affiliated to Southern Medical University, Foshan, People’s Republic of China *These authors contributed equally to this work Purpose: This study sought to define the role of adjuvant radiation therapy (RT) for patients with curative intent resection of perihilar cholangiocarcinoma (pCCA).Patients and methods: By using the Surveillance, Epidemiology and End Results (SEER) registry, 1,917 patients with non-metastatic pCCA who underwent surgical resection from 1988 to 2009 were included in this study. Propensity score methods were used to compare the survival outcomes of patients treated with and without adjuvant RT after controlling for selection bias.Results: Of the 1,917 patients, 762 (39.7%) received adjuvant RT. In the unmatched population, median overall survival (OS) for patients receiving adjuvant RT compared with those undergoing surgery alone was 23 versus 22 months (P=0.651). Patients who received adjuvant RT were younger (65 vs 68 years, P<0.001), had more regional diseases (86.0% vs 76.7%, P<0.001), and had more positive lymph nodes (43.8% vs 32.2%, P<0.001). In the matched population, adjuvant RT did not show better OS (22 vs 23 months, P=0.978) or cancer-specific survival (CSS) (17 vs 18 months, P=0.554).Conclusion: Adjuvant RT is not associated with improved survival of patients with resected pCCA. These data suggest that adjuvant RT should not be routinely used to treat patients with pCCA outside research trials. Ideally, prospective randomized trials should be performed to verify the conclusion of this study. Keywords: perihilar cholangiocarcinoma, radiation therapy, SEER, propensity score, survival, surgery |
topic |
Hilar cholangiocarcinoma Radiation therapy SEER Survival Surgery |
url |
https://www.dovepress.com/results-of-adjuvant-radiation-therapy-for-locoregional-perihilar-chola-peer-reviewed-article-OTT |
work_keys_str_mv |
AT lengkm resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection AT liuyp resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection AT wangzd resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection AT zhongxy resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection AT liaogq resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection AT kangpc resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection AT cuiyf resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection AT jiangxm resultsofadjuvantradiationtherapyforlocoregionalperihilarcholangiocarcinomaaftercurativeintentresection |
_version_ |
1725607811419734016 |